Mcmurray Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As psychedelics draw closer to legalization, companies in the industry have yet to figure out the most efficient and cost-effective way of producing psilocybin and other molecules on a commercial scale. To date, the industry has not reached a consensus as to the most effective production method to be used, once demand moves beyond clinical trials. PsyBio Therapeutics (TSXV:PSYB), a biotech company that uses genetically modified bacteria to biosynthesize psychedelic molecules, might have the answer to one of the industry’s most overlooked conundrums. Making Psilocybin From Bacteria PsyBio is...

Article content “The initial collaboration between PsyBio and Miami University has resulted in the discovery and scaled production of two medically relevant tryptamine molecules that are naturally present in psychoactive magic mushrooms, psilocybin and norbaeocystin,” said CEO Evan Levine, chairman of PsyBio. Now work at the lab will center around the development of microbes that produce a range of medically relevant organic compounds. “We are extraordinarily fortunate to have the resources and relationships at Miami University to attract institutional investment capital that is interes...

NA Proactive news snapshot: PsyBio Therapeutics, Numinus Wellness, Arizona Silver Exploration, Loop Insights, Canada Silver Cobalt Works … A glance at some of the day's highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive PsyBio Therapeutics Corp (CVE:PSYB) (FRA:PSYB) announced that it has amended its master-sponsored agreement with Miami University based in Oxford, Ohio for the continued advancement of its neuropsychiatric drug discovery platform. The Coconut Creek, Florida-based biotechnology company pioneering the ...

PsyBio and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform The McMurray Lab in Miami University plans to conduct IND-enabling, animal studies to verify the antidepressant, anti-addictive effects of the alkaloids produced in the Jones Lab The collaboration with Miami University is “anticipated to expediate progress" towards the filing of an IND application with the US FDA PsyBio Therapeutics Corp (CVE:PSYB) (FRA:PSYB) announced that it has amended its master-sponsored agreement with Miami University based in Oxford, Ohio for ...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA News provided by Share this article Share this article PsyBio" or the " Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the " Amended Agreement") to extend and expand the research efforts of the laboratory of Dr. J. Andrew Jones in the Department of Che...